{"mainPropery":{"diseaseId":2150,"diseaseName":"Dystrophic epidermolysis bullosa","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2150/dystrophic-epidermolysis-bullosa","synonyms":["DEB","Epidermolysis bullosa dystrophica","Dermolytic epidermolysis bullosa","Epidermolysis bullosa, dermolytic"],"synonyms-with-source":[{"name":"DEB"},{"name":"Epidermolysis bullosa dystrophica"},{"name":"Dermolytic epidermolysis bullosa"},{"name":"Epidermolysis bullosa, dermolytic"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"303"}]},"diseaseCategories":[{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases"}],"organizations":[{"resourceID":93,"resourceName":"Dystrophic Epidermolysis Bullosa Research Association of America","abbreviation":"DEBRA of America","address1":"75 Broad Street","address2":"Suite 300","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10004","country":"United States","phone":"212-868-1573","tty":"","tollFree":"855-CURE-4-EB","fax":"212-868-9296","email":"staff@debra.org","url":"http://www.debra.org"},{"resourceID":2754,"resourceName":"Epidermolysis Bullosa Medical Research Foundation","abbreviation":"EBMRF","address1":"2757 Anchor Ave","address2":"","address3":"","address4":"","address5":"","city":"Los Angeles","state":"CA","zip":"90064","country":"","phone":"+1-310-205-5119","tty":"","tollFree":"","fax":"","email":"a.pett@bep-la.com","url":"https://ebmrf.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Dystrophic%20epidermolysis%20bullosa%5Btitle%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Dystrophic epidermolysis bullosa. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Dystrophic+epidermolysis+bullosa%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Dystrophic epidermolysis bullosa. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/dystrophic-epidermolysis-bullosa' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Dystrophic epidermolysis bullosa. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":343,"resourceId":1160,"resourceName":"RareConnect- Epidermolysis Bullosa","descriptionText":"<a href='http://www.rareconnect.org/en/community/epidermolysis-bullosa ' target='_blank'>RareConnect</a> is an online social network for patients and families to connect with one another and share their experience living with a rare disease. The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders). Click on the link above to view the community for Epidermolysis bullosa.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":622,"resourceId":93,"resourceName":"Dystrophic Epidermolysis Bullosa Research Association of America","descriptionText":"<a href='http://www.debra.org/programs' target='_blank'>The Dystrophic Epidermolysis Bullosa Research Association of America, Inc. (DEBRA)</a> offers a National Physician Referral Service that connects people suffering with epidermolysis&nbsp;bullosa to qualified and knowledgeable health care professionals in their communities. Click on the link above to learn more about this and other services offered by the DEBRA.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0079294/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001457.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=303' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1304/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1562,"resourceId":2179,"resourceName":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","descriptionText":"The <a href='http://www.niams.nih.gov/Health_Info/Epidermolysis_Bullosa/default.asp' target='_blank'>National Institute of Arthritis and Musculoskeletal and Skin Diseases</a> (NIAMS) support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:4959' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2563,"resourceId":716,"resourceName":"DebRA International","descriptionText":"<a href='http://www.debra-international.org/clinical-guidelines.html' target='_blank'>DebRA International</a> has developed clinical practice guidelines for epidermolysis bullosa which provide recommendations for clinical care.&nbsp;These clinical guidelines are for patients as well as healthcare professionals.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Dystrophic epidermolysis bullosa. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Dystrophic epidermolysis bullosa:<br />\r\n<a href='https://ebcare.patientcrossroads.org/' target='_blank'>EBCare Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":6859,"questionText":"What is dystrophic epidermolysis bullosa?","answerText":"<strong>Dystrophic epidermolysis bullosa</strong> (DEB) is one of the major forms of <a href=\"http://rarediseases.info.nih.gov/gard/6359/Epidermolysis-bullosa/Resources/1\" target=\"_blank\">epidermolysis bullosa</a>. The signs and symptoms can vary widely among affected people. In mild cases, blistering may primarily affect the hands, feet, knees, and elbows. Severe cases often involve widespread blistering that can lead to vision loss, disfigurement, and other serious medical problems. DEB is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/COL7A1\" target=\"_blank\">COL7A1</a> </em>gene and may be inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>  or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner depending on the subtype.[5973][3103] New blisters should be lanced, drained, and protected. Some patients need nutritional support, supplements, occupational therapy and/or surgery depending on the associated&nbsp;features of the disease.[3103]","dateModified":"2015-09-29T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":2139,"relatedDiseaseName":"Dominant dystrophic epidermolysis bullosa","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":6359,"relatedDiseaseName":"Epidermolysis bullosa","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":2155,"relatedDiseaseName":"Pretibial epidermolysis bullosa","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12795,"relatedDiseaseName":"Recessive dystrophic epidermolysis bullosa ","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":12794,"relatedDiseaseName":"Recessive dystrophic epidermolysis bullosa-generalized other","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":6308,"relatedDiseaseName":"Severe generalized recessive dystrophic epidermolysis bullosa","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":1325,"phenoTypeName":"Abnormal blistering of the skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14465,"phenoTypeName":"Aplasia/Hypoplasia of the skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11841,"phenoTypeName":"Cheilitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13336,"phenoTypeName":"Dystrophic fingernails","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5050,"phenoTypeName":"Dystrophic toenail","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12617,"phenoTypeName":"Abnormality of dental enamel","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11669,"phenoTypeName":"Camptodactyly of finger","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10149,"phenoTypeName":"Carious teeth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13432,"phenoTypeName":"Esophageal stricture","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5020,"phenoTypeName":"Finger syndactyly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3106,"phenoTypeName":"Flexion contracture of toe","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14221,"phenoTypeName":"Furrowed tongue","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1833,"phenoTypeName":"Gangrene","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9285,"phenoTypeName":"Hypopigmented skin patches","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4762,"phenoTypeName":"Laryngeal stenosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9320,"phenoTypeName":"Milia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4739,"phenoTypeName":"Recurrent skin infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3891,"phenoTypeName":"Toe syndactyly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10228,"phenoTypeName":"Abnormality of the anus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15402,"phenoTypeName":"Acute constipation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5608,"phenoTypeName":"Blepharitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11326,"phenoTypeName":"Chronic otitis media","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":947,"phenoTypeName":"Corneal erosion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8976,"phenoTypeName":"Dilated cardiomyopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10132,"phenoTypeName":"Ectropion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10289,"phenoTypeName":"Eczema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1889,"phenoTypeName":"Glomerulopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":267,"phenoTypeName":"Immunologic hypersensitivity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10184,"phenoTypeName":"Interstitial pulmonary abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9168,"phenoTypeName":"Nasolacrimal duct obstruction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6347,"phenoTypeName":"Nephrotic syndrome","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3880,"phenoTypeName":"Phimosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10015,"phenoTypeName":"Renal insufficiency","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11788,"phenoTypeName":"Scarring","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7950,"phenoTypeName":"Squamous cell carcinoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9386,"phenoTypeName":"Stroke","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10001,"phenoTypeName":"Ureteral stenosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6442,"phenoTypeName":"Urinary retention","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Dystrophic_epidermolysis_bullosa"}